144 related articles for article (PubMed ID: 28469596)
1. Molecular Taxonomy of Sporadic Amyotrophic Lateral Sclerosis Using Disease-Associated Genes.
Morello G; Spampinato AG; Cavallaro S
Front Neurol; 2017; 8():152. PubMed ID: 28469596
[TBL] [Abstract][Full Text] [Related]
2. Integrative multi-omic analysis identifies new drivers and pathways in molecularly distinct subtypes of ALS.
Morello G; Guarnaccia M; Spampinato AG; Salomone S; D'Agata V; Conforti FL; Aronica E; Cavallaro S
Sci Rep; 2019 Jul; 9(1):9968. PubMed ID: 31292500
[TBL] [Abstract][Full Text] [Related]
3. Molecular classification of amyotrophic lateral sclerosis by unsupervised clustering of gene expression in motor cortex.
Aronica E; Baas F; Iyer A; ten Asbroek AL; Morello G; Cavallaro S
Neurobiol Dis; 2015 Feb; 74():359-76. PubMed ID: 25500340
[TBL] [Abstract][Full Text] [Related]
4. Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosis.
Lederer CW; Torrisi A; Pantelidou M; Santama N; Cavallaro S
BMC Genomics; 2007 Jan; 8():26. PubMed ID: 17244347
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional analysis reveals distinct subtypes in amyotrophic lateral sclerosis: implications for personalized therapy.
Morello G; Cavallaro S
Future Med Chem; 2015; 7(10):1335-59. PubMed ID: 26144267
[TBL] [Abstract][Full Text] [Related]
6. PACAP and PAC1R are differentially expressed in motor cortex of amyotrophic lateral sclerosis patients and support survival of iPSC-derived motor neurons.
Bonaventura G; Iemmolo R; D'Amico AG; La Cognata V; Costanzo E; Zappia M; D'Agata V; Conforti FL; Aronica E; Cavallaro S
J Cell Physiol; 2018 Apr; 233(4):3343-3351. PubMed ID: 28926110
[TBL] [Abstract][Full Text] [Related]
7. Neuroinflammation and ALS: Transcriptomic Insights into Molecular Disease Mechanisms and Therapeutic Targets.
Morello G; Spampinato AG; Cavallaro S
Mediators Inflamm; 2017; 2017():7070469. PubMed ID: 29081603
[TBL] [Abstract][Full Text] [Related]
8. Selection of Potential Pharmacological Targets in ALS Based on Whole- Genome Expression Profiling.
Morello G; Conforti FL; Parenti R; D'Agata V; Cavallaro S
Curr Med Chem; 2015; 22(17):2004-21. PubMed ID: 25850769
[TBL] [Abstract][Full Text] [Related]
9. Key Molecules and Pathways Underlying Sporadic Amyotrophic Lateral Sclerosis: Integrated Analysis on Gene Expression Profiles of Motor Neurons.
Lin J; Huang P; Chen W; Ye C; Su H; Yao X
Front Genet; 2020; 11():578143. PubMed ID: 33240324
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling for human iPS-derived motor neurons from sporadic ALS patients reveals a strong association between mitochondrial functions and neurodegeneration.
Alves CJ; Dariolli R; Jorge FM; Monteiro MR; Maximino JR; Martins RS; Strauss BE; Krieger JE; Callegaro D; Chadi G
Front Cell Neurosci; 2015; 9():289. PubMed ID: 26300727
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiles in sporadic ALS fibroblasts define disease subtypes and the metabolic effects of the investigational drug EH301.
Fels JA; Casalena G; Konrad C; Holmes HE; Dellinger RW; Manfredi G
Hum Mol Genet; 2022 Oct; 31(20):3458-3477. PubMed ID: 35652455
[TBL] [Abstract][Full Text] [Related]
12. RNA sequencing of peripheral blood in amyotrophic lateral sclerosis reveals distinct molecular subtypes: Considerations for biomarker discovery.
Grima N; Liu S; Southwood D; Henden L; Smith A; Lee A; Rowe DB; D'Silva S; Blair IP; Williams KL
Neuropathol Appl Neurobiol; 2023 Dec; 49(6):e12943. PubMed ID: 37818590
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms involved in the protective effect of pituitary adenylate cyclase-activating polypeptide in an in vitro model of amyotrophic lateral sclerosis.
Maugeri G; D'Amico AG; Rasà DM; Federico C; Saccone S; Morello G; La Cognata V; Cavallaro S; D'Agata V
J Cell Physiol; 2019 Apr; 234(4):5203-5214. PubMed ID: 30238989
[TBL] [Abstract][Full Text] [Related]
14. Copy-number variation in sporadic amyotrophic lateral sclerosis: a genome-wide screen.
Blauw HM; Veldink JH; van Es MA; van Vught PW; Saris CG; van der Zwaag B; Franke L; Burbach JP; Wokke JH; Ophoff RA; van den Berg LH
Lancet Neurol; 2008 Apr; 7(4):319-26. PubMed ID: 18313986
[TBL] [Abstract][Full Text] [Related]
15. Genotype-phenotype relationship in hereditary amyotrophic lateral sclerosis.
Yamashita S; Ando Y
Transl Neurodegener; 2015; 4():13. PubMed ID: 26213621
[TBL] [Abstract][Full Text] [Related]
16. Amyotrophic lateral sclerosis associated with genetic abnormalities in the gene encoding Cu/Zn superoxide dismutase: molecular pathology of five new cases, and comparison with previous reports and 73 sporadic cases of ALS.
Ince PG; Tomkins J; Slade JY; Thatcher NM; Shaw PJ
J Neuropathol Exp Neurol; 1998 Oct; 57(10):895-904. PubMed ID: 9786240
[TBL] [Abstract][Full Text] [Related]
17. New molecular diagnostic trends and biomarkers for amyotrophic lateral sclerosis.
Pampalakis G; Mitropoulos K; Xiromerisiou G; Dardiotis E; Deretzi G; Anagnostouli M; Katsila T; Rentzos M; Patrinos GP
Hum Mutat; 2019 Apr; 40(4):361-373. PubMed ID: 30556231
[TBL] [Abstract][Full Text] [Related]
18. Unsupervised machine learning identifies distinct ALS molecular subtypes in post-mortem motor cortex and blood expression data.
Marriott H; Kabiljo R; Hunt GP; Khleifat AA; Jones A; Troakes C; ; ; Pfaff AL; Quinn JP; Koks S; Dobson RJ; Schwab P; Al-Chalabi A; Iacoangeli A
Acta Neuropathol Commun; 2023 Dec; 11(1):208. PubMed ID: 38129934
[TBL] [Abstract][Full Text] [Related]
19. Genomic variants in the FTO gene are associated with sporadic amyotrophic lateral sclerosis in Greek patients.
Mitropoulos K; Merkouri Papadima E; Xiromerisiou G; Balasopoulou A; Charalampidou K; Galani V; Zafeiri KV; Dardiotis E; Ralli S; Deretzi G; John A; Kydonopoulou K; Papadopoulou E; di Pardo A; Akcimen F; Loizedda A; Dobričić V; Novaković I; Kostić VS; Mizzi C; Peters BA; Basak N; Orrù S; Kiskinis E; Cooper DN; Gerou S; Drmanac R; Bartsakoulia M; Tsermpini EE; Hadjigeorgiou GM; Ali BR; Katsila T; Patrinos GP
Hum Genomics; 2017 Dec; 11(1):30. PubMed ID: 29216901
[TBL] [Abstract][Full Text] [Related]
20. Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex.
Thomsen GM; Gowing G; Latter J; Chen M; Vit JP; Staggenborg K; Avalos P; Alkaslasi M; Ferraiuolo L; Likhite S; Kaspar BK; Svendsen CN
J Neurosci; 2014 Nov; 34(47):15587-600. PubMed ID: 25411487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
